Ifinatamab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Neuroendocrine Tumors.
HCA Healthcare Collaborates with Google Cloud to Bring Generative AI to Hospitals
What You Should Know: – HCA Healthcare and Google Cloud today announced a new collaboration designed to use generative AI technology to improve workflows on